Self-reported cognitive impairment in patients with cancer

Journal of Oncology Practice

Volumn 3, Issue 2, 2007, Pages 54-59

  Kohli, Sadhna ^a   Griggs, Jennifer J ^a   Roscoe, Joseph A ^a   Jean Pierre, Pascal ^a   Bole, Christopher ^a   Mustian, Karen M ^a   Hill, Renae ^a   Smith, Kelly ^a   Gross, Howard ^a   Morrow, Gary R ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; COGNITIVE DEFECT; CONCENTRATION LOSS; DISEASE SEVERITY; FEMALE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MEMORY DISORDER; MULTIMODALITY CANCER THERAPY; SELF REPORT; SOLID TUMOR; TREATMENT OUTCOME;

EID: 42649124647     PISSN: 15547477     EISSN: None     Source Type: Journal    
DOI: 10.1200/JOP.0722001     Document Type: Article

References (14)

1. Ahles TA, Saykin A. Cognitive effects of standard-dose chemotherapy in patients with cancer. Cancer Invest 19:812-820, 2001
2. Ahles TA, Saykin AJ, Furstenberg CT, et al: Neuropsychologic impact of standard-dose systemic chemotherapy in long-term survivors of breast cancer and lymphoma. J Clin Oncol 20:485-493, 2002
3. Rugo HS, Ahles T: The Impact of adjuvant therapy for breast cancer on cognitive function: Current evidence and directions for research. Semin Oncol 30: 749-762, 2003
4. Schagen SB, van Dam FS, Muller MJ, et al: Cognitive deficits after postoperative adjuvant chemotherapy for breast carcinoma. Cancer 85:640-650, 1999
5. Ferguson RJ, Ahles TA: Low neuropsychologic performance among adult cancer survivors treated with chemotherapy. Curr Neurol Neurosci Rep 3:215-222, 2003.
6. Mayers CA, Geara F, Wong PF, et al: Neurocognitive effects of therapeutic Irradiation for base of skull tumors. Int J Radiat Oncol Biol Phys 46:51-55, 2000
7. Olin JJ: Cognitive function after systemic therapy for breast cancer. Oncology (Huntington) 15:613-618, 2001
8. Phillips KA, Bernhard J: Adjuvant breast cancer treatment and cognitive function: Current knowledge and research drections. J Natl Cancer Inst 95:190-197, 2003
9. Silberfarb PM: Chemotherapy and cognitive defects in cancer patients. Ann Rev Med 34:35-46, 1983
10. Welch SE, Ahles TA, Saykin AJ: Neuropsychological impact of cancer and cancer treatments, in: Holland JC, Breltbart W, Jacobson PB (eds): Psycho-Oncology. New York, NY, Oxford University Press, 1998, pp 500-505
11. Cleeland CS, Mendoza TR, Wang XS, et al: Assessing symptom distress in cancer patients: The M.D. Anderson Symptom Inventory. Cancer 89:1634-1646, 2000
12. Meyers CA, Albitar M, Estey E: Cognitive impairment, fatigue, and cytokine levels in patiens with acute myelogenous leukemia or myelodysplastic syndrome. Cancer 104:788-793, 2005
13. Wefel JS, Lenzi R, Thleriault R, et al: A "chemobrain" in breast cancer? Cancer 101:466-474, 2004
14. Shilling V, Jenkins V: Self-reported cognitive problems in women receiving adjuvant therapy for breast cancer. Euro J Oncol Nurs, 2006